“The Role of SOX2 in Barrett’s Esophagus Development and Esophageal Homeostasis” DDRCC Sponsored Gastroenterology Division Research Conference, Invited Speaker | St. Louis, MO 09/2024 |
“The Role of SOX2 in Barrett’s Esophagus Development and Esophageal Homeostasis” CWRU Pathways of Injury and Repair in Barrett’s Carcinogenesis PPG, Invited Speaker | Virtual 07/2024 |
“The Role of SOX2 in Barrett’s Esophagus Development and Esophageal Homeostasis” Digestive Disease Week 2024, Invited Speaker | Washington, DC 05/2024 |
“The Role of SOX2 in Barrett’s Esophagus Development” Wash U Medical Oncology Grant Rounds, Invited Speaker | St. Louis, MO 02/2024 |
“The Role of SOX2 in Barrett’s Esophagus Development” Eastern Alliance DDRCC Exchange Program, Invited Speaker | Baltimore, MD 06/2023 |
“The Role of SOX2 in Barrett’s Esophagus Development” AACR Annual Meeting 2023 | Orlando, FL 04/2023 |
“Gastric Cancer Disease Overview: Unmet Biological and Clinical Questions” CPTAC Steering Committee Meeting, Invited Speaker | Bethesda, MD 03/2023 |
“The Role of SOX2 in Barrett’s Esophagus and Esophageal Adenocarcinoma” Wash U DDRCC GI Research Conference, Invited Speaker | St. Louis, MO 02/2023 |
“The Role of SOX2 in Barrett’s Esophagus Development” 2022 DDRCC Directors Meeting | Charleston, SC 10/2022 |
“The Role of SOX2 in Barrett’s Esophagus Development” FASEB GI Tract XX: Making and Breaking the Gut, Invited Speaker | Steamboat Springs, CO 08/2022 |
“The Role of UBE2C in Barrett’s Esophagus Development and Progression to Esophageal Adenocarcinoma” Digestive Disease Week 2022, Invited Speaker | San Diego, CA 05/2022 |
“Role of UBE2C in Progression to Cancer” BETRNet 10th Annual Steering Committee Meeting, Invited Speaker | Virtual 10/2021 |
“The Role of SOX2 and CDX2 in Barrett’s Esophagus” CCHMC-Endoderm Club, Invited Speaker | Virtual 10/2021 |
“A Human Organoid Biobank to Study Tissue Plasticity of Barrett’s Esophagus” Digestive Disease Week 2021 | Virtual 05/2021 |
“Tropism of SARS-CoV-2 for Barrett’s Esophagus may Increase Susceptibility to Developing COVID-1” Digestive Disease Week 2021 | Virtual 05/2021 |
“A Human Organoid Biobank to Study Tissue Plasticity of Barrett’s Esophagus” Keystone Symposia Tissue Plasticity: Preservation and Alteration of Cellular Identity | Keystone, CO 10/2020 |
“Final Results of a Phase 2 Trial of First-line FOLFIRINOX for Advanced Gastroesophageal Cancers” 2020 ASCO Annual Meeting | Chicago, IL 05/2020 |
“Paligenosis is a Key Damage Response Pathway for Esophageal Adenocarcinoma” Keystone Symposia: Cellular Plasticity: Reprogramming, Regeneration and Metaplasia | Keystone, CO 01/2019 |
“RAB26, a transcriptional target of MIST1, regulates lysosomal trafficking in exocrine secretory cells” ASCI/AAP/APSA Annual Meeting | Chicago, IL 04/2012 |
“RAB26, a direct transcriptional target of MIST1, is a novel regulator of lysosome positioning” FASEB GI Tract XIV: Stem Cells, Adaptation, Inflammation and Cancer | Steamboat Springs, CO 08/2011 |
“RAB26 is required for formation of large exocrine secretory vesicles and is sufficient to reposition lysosomes” Gordon Research Conference: Proprotein Processing, Trafficking & Secretion | New London, NH 07/2010 |
“RAB26, a direct transcriptional target of MIST1, is required for formation of large exocrine secretory vesicles” | Chicago, IL 04/2010 |
“RAB26, a direct transcriptional target of MIST1, is required for formation of large exocrine secretory vesicles” FASEB GI Tract XII: The Molecular and Integrative Basis for GI Development, Homeostasis and Disease | Snowmass, CO 08/2009 |
“The cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice” The Endocrine Society’s Annual Meeting, Invited Speaker | San Diego, CA 06/2005 |